Peanut allergy vaccine shows promise in early safety trial
NCT ID NCT05476497
First seen Mar 15, 2026 · Last updated May 21, 2026 · Updated 9 times
Summary
This early-stage study tests a new treatment called VLP Peanut in 46 healthy adults and those with peanut allergy. The main goal is to see if it is safe and tolerable, while also looking for early signs that it might reduce allergic reactions. Participants receive the treatment and are monitored for side effects like tiredness or headache.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PEANUT ALLERGY are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Cleveland Clinic Foundation
Cleveland, Ohio, 44195, United States
-
Icahn School of Medicine at Mount Sinai
New York, New York, 10029, United States
-
Massachusetts General Hospital
Boston, Massachusetts, 02114, United States
-
Mayo Clinic
Rochester, Minnesota, 55905, United States
-
Trio Clinical Trials, LLC.
Houston, Texas, 77008, United States
-
University of Arizona
Tucson, Arizona, 85724, United States
-
University of Kansas Medical Center
Kansas City, Kansas, 66160, United States
-
University of South Florida
Tampa, Florida, 33613, United States
-
University of Wisconsin School of Medicine and Public Health Asthma, Allergy, and Pulmonary Clinical Research
Madison, Wisconsin, 53792-9988, United States
-
Washington University School of Medicine
St Louis, Missouri, 63141, United States
Conditions
Explore the condition pages connected to this study.